Abstract
Cancer cells produce high levels of reactive oxygen species (ROS) that lead to a state of increased basal oxidative stress. Since this state of oxidative stress makes cancer cells vulnerable to agents that further augment ROS levels, the use of pro-oxidant agents is emerging as an exciting strategy to selectively target tumor cells. Natural products have provided a significant contribution to the development of several drugs currently used in cancer chemotherapy. Although many natural products are known to affect the redox state of the cell, most studies on these compounds have focused on their antioxidant activity instead of on their pro-oxidant properties. This article provides an overview of natural products with pro-oxidant and anticancer activities, with special focus on plant secondary metabolites, and discusses their possible use as cancer chemotherapeutic agents.
Keywords: Alkaloids, cancer, hydrogen peroxide, phenolic compounds, plant secondary metabolites, prooxidant, reactive oxygen species, terpenoids, Anticancer Agents, oxidative stress, Natural products
Current Drug Targets
Title:Pro-Oxidant Natural Products as Anticancer Agents
Volume: 13 Issue: 8
Author(s): Carmen Martin-Cordero, Antonio Jose Leon-Gonzalez, Jose Manuel Calderon-Montano, Estefania Burgos-Moron and Miguel Lopez-Lazaro
Affiliation:
Keywords: Alkaloids, cancer, hydrogen peroxide, phenolic compounds, plant secondary metabolites, prooxidant, reactive oxygen species, terpenoids, Anticancer Agents, oxidative stress, Natural products
Abstract: Cancer cells produce high levels of reactive oxygen species (ROS) that lead to a state of increased basal oxidative stress. Since this state of oxidative stress makes cancer cells vulnerable to agents that further augment ROS levels, the use of pro-oxidant agents is emerging as an exciting strategy to selectively target tumor cells. Natural products have provided a significant contribution to the development of several drugs currently used in cancer chemotherapy. Although many natural products are known to affect the redox state of the cell, most studies on these compounds have focused on their antioxidant activity instead of on their pro-oxidant properties. This article provides an overview of natural products with pro-oxidant and anticancer activities, with special focus on plant secondary metabolites, and discusses their possible use as cancer chemotherapeutic agents.
Export Options
About this article
Cite this article as:
Martin-Cordero Carmen, Jose Leon-Gonzalez Antonio, Manuel Calderon-Montano Jose, Burgos-Moron Estefania and Lopez-Lazaro Miguel, Pro-Oxidant Natural Products as Anticancer Agents, Current Drug Targets 2012; 13 (8) . https://dx.doi.org/10.2174/138945012802009044
DOI https://dx.doi.org/10.2174/138945012802009044 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toll-Like Receptor 4 and Heat-Shock Protein 70: Is it a New Target Pathway for Diabetic Vasculopathies?
Current Drug Targets Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies
Current Drug Delivery Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Angiotensin Converting Enzyme Inhibitor in Coronary Artery Bypass Surgery
Drug Design Reviews - Online (Discontinued) Can Diabetes Heal?- From Observations to Perspectives
Current Diabetes Reviews A Dilemma of Functional Genomics: Count the Chickens or Study their Eggs ?
Current Genomics Small Molecules as Anti-TNF Drugs
Current Medicinal Chemistry The Mechanism of Adjuvanticity of Aluminium-Containing Formulas
Current Pharmaceutical Design The Advancement of Human Serum Albumin-Based Molecular Probes for Molecular Imaging
Current Pharmaceutical Design Computational Models for Predicting Interactions with Cytochrome p450 Enzyme
Current Topics in Medicinal Chemistry Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome
Infectious Disorders - Drug Targets Natural Products on Nonalcoholic Fatty Liver Disease
Current Drug Targets Editorial: Exciting Progresses in Stem Cell and Neural Stem Cell Research
Current Molecular Medicine Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets Nanoparticles in Melanoma
Current Medicinal Chemistry ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Current Neuropharmacology Malnutrition in Patients with End-Stage Renal Disease - Anorexia,Cachexia and Catabolism
Current Nutrition & Food Science Sedation and Analgesia in Pediatric Intensive Care
Current Drug Targets Anti-Adhesion Molecules: is Gut Specificity the Key for a Good Safety Profile?
Current Drug Delivery Adenosine A1 Receptors in the Central Nervous System: Their Functions in Health and Disease, and Possible Elucidation by PET Imaging
Current Medicinal Chemistry